• Ep. 250 - Biosecure, Priority Review Vouchers & Target Discovery

  • Sep 4 2024
  • Length: 30 mins
  • Podcast

Ep. 250 - Biosecure, Priority Review Vouchers & Target Discovery

Listen for free

View show details

  • Summary

  • A vote on the Biosecure Act in the U.S. House of Representatives early next week shines the spotlight back on legislation seeking to rein in Chinese CDMOs and genomics companies, as Congress returns to work. On the latest BioCentury This Week podcast, BioCentury’s editors handicap the legislation’s chances of passage in the House and Senate and assess what’s at stake for the law authorizing rare pediatric disease priority review vouchers.
    They also discuss the results of BioCentury’s snap poll gauging the biopharma industry’s reaction to the IRA Medicare drug price negotiation program, recalling the latest trends among pharma’s deals with biotechs over the past 12 months. Plus, a preview BioCentury’s annual Back to School package, next week’s new Grand Rounds R&D conference and highlights from this month’s Distillery roundup of translational papers.

    View full story: https://www.biocentury.com/article/653385


    00:00 - Introduction
    01:36 - Biosecure on Deck
    04:33 - Priority Review Vouchers
    08:11 - BioCentury IRA Survey
    17:07 - Back to School: Target Discovery
    19:49 - Translational Highlights

    Reach us by sending a text
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Show more Show less

What listeners say about Ep. 250 - Biosecure, Priority Review Vouchers & Target Discovery

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available